AstraZeneca PLC
LSE:AZN
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
ROE Comparison
AstraZeneca PLC Competitors
| Country | UK |
| Market Cap | 185.4B GBP |
| ROE |
16%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| ROE |
-441%
|
| Country | US |
| Market Cap | 695.1B USD |
| ROE |
49%
|
| Country | DK |
| Market Cap | 3.8T DKK |
| ROE |
88%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| ROE |
-4%
|
| Country | JP |
| Market Cap | 82T JPY |
| ROE |
1%
|
| Country | US |
| Market Cap | 357.5B USD |
| ROE |
56%
|
| Country | US |
| Market Cap | 321.5B USD |
| ROE |
1%
|
| Country | CH |
| Market Cap | 184.6B CHF |
| ROE |
28%
|
| Country | CH |
| Market Cap | 176.1B CHF |
| ROE |
40%
|
| Country | US |
| Market Cap | 148.3B USD |
| ROE |
2%
|
Profitability Report
View the profitability report to see the full profitability analysis for AstraZeneca PLC.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on AstraZeneca PLC's most recent financial statements, the company has ROE of 15.6%.
You don't have any saved screeners yet
